Literature DB >> 21161294

Intracranial recurrences of Rosai-Dorfman disease in the sellar region: two illustrative cases.

Fulin Wang1, Guangyu Qiao, Xin Lou, Xin Song, Wei Chen.   

Abstract

Rosai-Dorfman disease [RDD] is a condition of an unknown etiology, characterized by proliferation of histiocytes. Not uncommonly extranodal lesions occur, but sellar involvement is very rare. Treatment of this lesion is complicated, especially in cases of recurrences at multiple intracranial sites. We report two cases of RDD in the sellar region with intracranial recurrences to illustrate the clinicopathological features and considerations of the optimal management.

Entities:  

Mesh:

Year:  2010        PMID: 21161294     DOI: 10.1007/s00701-010-0895-z

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  Patterns and Implications of Intracranial Arterial Remodeling in Stroke Patients.

Authors:  Ye Qiao; Zeeshan Anwar; Jarunee Intrapiromkul; Li Liu; Steven R Zeiler; Richard Leigh; Yiyi Zhang; Eliseo Guallar; Bruce A Wasserman
Journal:  Stroke       Date:  2016-01-07       Impact factor: 7.914

Review 2.  Intracranial Rosai-Dorfman disease with the petroclival and parasellar involvement mimicking multiple meningiomas: A case report and review of literature.

Authors:  Chao Wang; Pingding Kuang; Fangfang Xu; Ling Hu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

3.  Case Report: Rosai-Dorfman Disease Involving Sellar Region in a Pediatric Patient: A Case Report and Systematic Review of Literature.

Authors:  Yi Zhang; Jie Liu; Jianyu Zhu; Xiang Zhou; Kun Zhang; Shirui Wang; Wenbin Ma; Hui Pan; Renzhi Wang; Huijuan Zhu; Yong Yao
Journal:  Front Med (Lausanne)       Date:  2020-11-30

Review 4.  Isolated intracranial Rosai-Dorfman disease mimicking petroclival meningioma in a child: Case report and review of the literature.

Authors:  Xiang Yang; Jiagang Liu; Yanming Ren; Seidu A Richard; Yuekang Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.